Dipeptidyl Peptidase 4 Inhibitors Gliptins For Type 2 Diabetes Mellitus. Preclinical data and mechanistic studies have indicated a possible beneficial action on blood. Esposito k, cozzolino d, bellastella g, et al.
He prevalence of type 2 diabetes mellitus (t2dm) is increasing worldwide.
Type 2 diabetes mellitus is a growing global public health problem, the prevalence of which is projected to increase in the succeeding decades. Gail mkele, bpharm msc(med)pharm correspondence to: There were some types of gliptins found very important as oral drugs against the disease. Comparison of vildagliptin and rosiglitazone monotherapy in patients with type 2 diabetes:
Post a Comment for "Dipeptidyl Peptidase 4 Inhibitors Gliptins For Type 2 Diabetes Mellitus"